Search

everythinglearnresearchcommunity

for

Search:↓

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Lower allopregnanolone levels increase stress-related dopamine release in the brain.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

Targeting the PGD2-DP2 pathway may help treat hair loss.

Topical finasteride may help treat facial hirsutism in women.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Spironolactone is effective for idiopathic hirsutism but has limited effects on other PCOS symptoms.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Diane and Androcur 10 improved acne and seborrhea in most women, and hirsutism and alopecia in about half.

Adding a specific gene to skin cells can help treat skin disorders like psoriasis.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Elevated testosterone, DHEA-S, and FAI help identify PCOS risk in menstrual irregularities.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Blocking Prostaglandin D₂ (PGD₂) could help treat hair loss.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Dexamethasone effectively normalizes elevated steroid levels in girls with premature adrenarche.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

Nonclassic 21-hydroxylase deficiency is a common, treatable genetic disorder causing reversible symptoms like acne and hair loss.

Higher levels of DHEA and TNF-α are linked to PCOS symptoms.

Researchers had trouble finding enough participants for a trial on DHEA's effects on postmenopausal women's sexual desire.

PCOS involves high 11-oxygenated androgens and BPA may worsen it, while IH is not inflammatory.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

Using 5-butylpicolinate esters improves the sensitivity and reliability of detecting testosterone and dihydrotestosterone in saliva.

The normal human prostate does not significantly affect blood DHT levels.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

New genes and pathways are important for testosterone production and male sexual development.